08:00 , Dec 4, 2008 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Acute myelogenous leukemia (AML) Cadherin-like 24 (CDH24); solute carrier family 15 (oligopeptide transporter), member 1 (SLC15A); kinase non-catalytic C-lobe domain (KIND)...